MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank40
3Y CAGR-23.8%
5Y CAGR+13.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-23.8%/yr
Annual compound
5Y CAGR
+13.3%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.79 | -63.4% |
| 2024 | 7.62 | +27.3% |
| 2023 | 5.98 | -5.1% |
| 2022 | 6.30 | +120.1% |
| 2021 | -31.36 | -2195.6% |
| 2020 | 1.50 | - |